A question for the more medical minded amongst us. As the company looks at other neuromuscular diseases that ATL1102 could potentially treat, how does ALS disease fit in amongst them, if at all ?
I've read the causes and symptoms, I just can't see if the anti inflammatory capabilities of ATL1102 have a place in the treatment.
Other indications
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.32M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6865 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.8¢ | 141632 | 3 |
View Market Depth
| Last trade - 10.29am 25/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable